Adult Vaccines Market, By Vaccine (Influenza, Tetanus/Diphtheria/Pertussis, Varicella, Human Papillo

Published Date: | Report Code : HC2067816


Adult Vaccines Market, By Vaccine (Influenza, Tetanus/Diphtheria/Pertussis, Varicella, Human Papillomavirus, Zoster, Measles/mumps/Rubella, Pneumococcal, Hepatitis, and Others), By Vaccine Type (Monovalent and Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Conjugate Vaccines), By Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) – Market Size & Forecasting To 2028

COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.

Domain : Healthcare

Report Code : HC2067816

Status : Upcoming

The Adult Vaccines Market report points out national and global business prospects and competitive conditions for Adult vaccines. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for Adult vaccines. The Adult vaccines market has been segmented by vaccine (influenza, tetanus/diphtheria/pertussis, varicella, human papillomavirus, zoster, measles/mumps/rubella, pneumococcal, hepatitis, and others), by vaccine type (monovalent and multivalent), by technology (live attenuated vaccines, inactivated viral or bacterial vaccines, toxoid vaccines, recombinant vaccines, and conjugate vaccines). Historical background for the demand of Adult vaccines has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand Adult vaccines have also been established with potential gravity. Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Market Segmentation:

By Vaccine:   

  • Influenza
  • Tetanus/Diphtheria/Pertussis
  • Varicella
  • Human Papillomavirus
  • Zoster
  • Measles/mumps/Rubella
  • Pneumococcal
  • Hepatitis
  • and Others

By Vaccine Type:   

  • Monovalent
  • and Multivalent

By Technology:

  • Live Attenuated Vaccines
  • Inactivated Viral or Bacterial Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • and Conjugate Vaccines

By Region:

North America Adult Vaccines Market

  • North America, by Country
    • US
    • Canada
    • Mexico
  • North America, by Vaccine
  • North America, by Vaccine Type
  • North America, by Technology

Europe Adult Vaccines Market

  • Europe, by Country
    • Germany
    • Russia
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
    • Rest of Europe 
  • Europe, by Vaccine
  • Europe, by Vaccine Type
  • Europe, by Technology

Asia Pacific Adult Vaccines Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Rest of Asia Pacific 
  • Asia Pacific, by Vaccine
  • Asia Pacific, by Vaccine Type
  • Asia Pacific, by Technology

Middle East & Africa Adult Vaccines Market

  • Middle East & Africa, by Country 
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East & Africa
  • Middle East & Africa, by Vaccine
  • Middle East & Africa, by Vaccine Type
  • Middle East & Africa, by Technology

South America Adult Vaccines Market

  • South America, by Country 
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • South America, by Vaccine
  • South America, by Vaccine Type
  • South America, by Technology

Major Companies: GlaxoSmithKline Plc, Merck & Co., Sanofi Pasteur, Pfizer, Inc., CSL Limited, Johnson & Johnson, Serum Institute of India, Medimmune, and AstraZeneca Plc.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Objectives of this report:

  • To estimate market size for Adult vaccines market on regional and global basis.
  • To identify major segments in Adult vaccines market and evaluate their market shares and demand.
  • To provide a competitive scenario for the Adult vaccines market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of Adult vaccines market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Provides niche insights for decision about every possible segment helping in strategic decision making process.
  • Market size estimation of the Adult vaccines market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the Adult vaccines market.


This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis

For more information, contact: [email protected]

License Offering

Single User (PDF)


Multi User (PDF)


Enterprise User (PDF)


Get Regional Report @ USD 2000 Only

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy